These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 16316)
41. Maintenance treatment of schizophrenia with long-acting fluphenazine. Niturad A; Ciurezu T; Cucu I Act Nerv Super (Praha); 1974 Aug; 16(3):167. PubMed ID: 4154028 [No Abstract] [Full Text] [Related]
42. Diphenhydramine dependence: a need for awareness. de Nesnera AP J Clin Psychiatry; 1996 Mar; 57(3):136-7. PubMed ID: 8617701 [No Abstract] [Full Text] [Related]
43. Tardive dyskinesia. McAfee HA Am J Nurs; 1978 Mar; 78(3):359-7. PubMed ID: 25020 [No Abstract] [Full Text] [Related]
44. [Clopixol: new possibilities in therapy of mental disorders (a review of clinical studies)]. Litvintsev SV; Reznik AM; Arbuzov AL; Barkov DA Voen Med Zh; 2002 Mar; 323(3):42-7. PubMed ID: 11965908 [No Abstract] [Full Text] [Related]
45. Advances in drug treatment in psychiatry. Barnes TR; Bridges PK Practitioner; 1978 Oct; 221(1324):513-20. PubMed ID: 33374 [No Abstract] [Full Text] [Related]
47. [Drug therapy of mental disorders and the eye (review)]. Gol'dovskaia IL Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(3):119-26. PubMed ID: 6123209 [No Abstract] [Full Text] [Related]
48. Future of depot neuroleptic therapy: pharmacokinetic and pharmacodynamic approaches. Ereshefsky L; Saklad SR; Jann MW; Davis CM; Richards A; Seidel DR J Clin Psychiatry; 1984 May; 45(5 Pt 2):50-9. PubMed ID: 6143748 [TBL] [Abstract][Full Text] [Related]
49. [Use of fluphenazine oenanthate in psychiatric therapy (personal experience)]. Darcourt G; Lavagna J; Myquel M; Bècle J Ann Med Psychol (Paris); 1971 Oct; 2(3):448-59. PubMed ID: 5128638 [No Abstract] [Full Text] [Related]
51. [Adverse effects of long-acting fluphenazine]. Lievre JA; Guillien P; Boccara M Presse Med (1893); 1971 Sep; 79(40):1757. PubMed ID: 5120822 [No Abstract] [Full Text] [Related]
52. [Trial of delayed-action neuroleptics in the treatment of acute psychotic conditions]. Gayral L; Escande M; Fournié H; Perretti A Ann Med Psychol (Paris); 1972 Mar; 1(3):381-94. PubMed ID: 5053751 [No Abstract] [Full Text] [Related]
53. Conformationally restricted phenothiazines. Martin AB Psychopharmacol Bull; 1979 Jan; 15(1):53. PubMed ID: 33408 [No Abstract] [Full Text] [Related]
54. ASSESSMENT OF MENTAL ALERTNESS AFTER ADMINISTRATION OF VARIOUS PHENOTHIAZINES. DIXIT YB; AMIN MG; PATHAK JD J Indian Med Assoc; 1964 Feb; 42():173-5. PubMed ID: 14115860 [No Abstract] [Full Text] [Related]
55. Plasma fluphenazine levels measured by high-performance liquid chromatography in patients treated with depot injections. Jouen F; Verité P; André D; Colonna L; Boucly P Arzneimittelforschung; 1993 May; 43(5):509-11. PubMed ID: 8328993 [TBL] [Abstract][Full Text] [Related]
56. [Statistical method of analysis and evaluation of therapeutic results in psychiatry. Example of application to a delayed-action neuroleptic and comparison with a standard neuroleptic and with Sakel's insulin treatment]. Gayral L; Caussinus H; Schecktman Y Therapie; 1970; 25(1):29-42. PubMed ID: 5436802 [No Abstract] [Full Text] [Related]
57. Phenothiazines and other tranquilizers. Lear E Clin Anesth; 1974; 10(1):185-206. PubMed ID: 4149701 [No Abstract] [Full Text] [Related]
58. [Experience with leptril therapy for preschool children]. Semenovskaia EI; Rozengauz RA Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(10):1579-82. PubMed ID: 4149525 [No Abstract] [Full Text] [Related]
59. Antiemetic action of fluphenazine (Prolixin): a comparison with other phenothiazines. LAFFAN RJ; PAPANDRIANOS DP; BURKE JC; CR AVER BN J Pharmacol Exp Ther; 1961 Jan; 131():130-4. PubMed ID: 13758172 [No Abstract] [Full Text] [Related]
60. The risk/benefit ratio of depot neuroleptics: a Scandinavian perspective. Dencker SJ J Clin Psychiatry; 1984 May; 45(5 Pt 2):22-7. PubMed ID: 6143744 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]